Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Saptak Chem and Business Limited has received BSE trading approval for 10,73,227 equity shares of Rs. 10 each, effective from September 17, 2025. These shares are being re-listed following a Scheme of Reduction of Capital approved by NCLT, Ahmedabad on June 23, 2025. Under the scheme, the company reduced its equity share capital by 90% — from Rs. 10.73 crore (1,07,32,272 shares) to Rs. 1.07 crore (10,73,227 shares) — to write off accumulated losses of Rs. 9.65 crore (out of total losses of Rs. 12.87 crore as of March 31, 2023). The record date for the reduction was July 5, 2025. Shares will trade in the XT group under Trade-to-Trade segment with scrip code 506906.
Existing shareholders have effectively seen their holdings reduced to 10% of what they previously held, as 90% of shares were cancelled to clean up past losses. The re-listing allows continued trading but the stock's price may adjust sharply to reflect the lower share count and the loss write-off.